Compare
Ingevity Corp vs Balchem Corp vs Innospec Inc. vs Ecovyst Inc.
| Latest fiscal year | Ingevity Corp NGVT | Balchem Corp BCPC | Innospec Inc. IOSP | Ecovyst Inc. ECVT |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $1.17B | $1.04B | $1.78B | $723.51M |
| Revenue growth (YoY) | -2.7% | +8.8% | -3.7% | +20.9% |
| Gross margin | 39.5% | 35.7% | 27.7% | 21.8% |
| Operating margin | 35.9% | 20.2% | 7.3% | 9.0% |
| Net margin | -14.3% | 14.9% | 6.6% | -9.8% |
| Net income | -$167.10M | $154.84M | $116.60M | -$71.13M |
| EPS (Diluted) | -$4.61 | $4.75 | $4.67 | -$0.61 |
| Operating cash flow | $331.20M | $216.56M | $138.30M | $140.31M |
| Free cash flow | $273.50M | n/a | n/a | $69.89M |
| Cash & equivalents | $78.10M | $74.57M | $292.50M | $197.19M |
| Total assets | $1.65B | $1.69B | $1.83B | $1.26B |
| Total liabilities | $1.62B | $428.84M | $499.50M | $657.54M |
| Shareholders' equity | $29.70M | $1.26B | $1.33B | $603.44M |
| Return on year-end equity | -562.6% | 12.3% | 8.8% | -11.8% |
| Shares outstanding | 35.49M | 32.06M | n/a | 111.81M |
Revenue, most recent five fiscal years
| Fiscal year | Ingevity Corp | Balchem Corp | Innospec Inc. | Ecovyst Inc. |
|---|---|---|---|---|
| Latest | $1.17B Ended 2025-12-31 | $1.04B Ended 2025-12-31 | $1.78B Ended 2025-12-31 | $723.51M Ended 2025-12-31 |
| 1 year earlier | $1.20B Ended 2024-12-31 | $953.68M Ended 2024-12-31 | $1.85B Ended 2024-12-31 | $598.29M Ended 2024-12-31 |
| 2 years earlier | $1.22B Ended 2023-12-31 | $922.44M Ended 2023-12-31 | $1.95B Ended 2023-12-31 | $584.85M Ended 2023-12-31 |
| 3 years earlier | $1.67B Ended 2022-12-31 | $942.36M Ended 2022-12-31 | $1.96B Ended 2022-12-31 | $820.16M Ended 2022-12-31 |
| 4 years earlier | $1.39B Ended 2021-12-31 | $799.02M Ended 2021-12-31 | $1.48B Ended 2021-12-31 | $611.20M Ended 2021-12-31 |